Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge
Crit Care
.
2015 Jun 22;19(1):263.
doi: 10.1186/s13054-015-0953-2.
Authors
Patrick M Honore
1
,
Rita Jacobs
2
,
Inne Hendrickx
2
,
Elisabeth De Waele
2
,
Viola Van Gorp
2
,
Herbert D Spapen
2
Affiliations
1
ICU Department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium. Patrick.Honore@az.vub.ac.be.
2
ICU Department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
PMID:
26095659
PMCID:
PMC4476232
DOI:
10.1186/s13054-015-0953-2
No abstract available
Publication types
Comment
MeSH terms
Anti-Bacterial Agents / pharmacokinetics*
Extracorporeal Membrane Oxygenation*
Female
Humans
Male
Renal Replacement Therapy*
Thienamycins / pharmacokinetics*
Substances
Anti-Bacterial Agents
Thienamycins